Published in Ann Gastroenterol on January 01, 2013
Advances in nutritional therapy in inflammatory bowel diseases: Review. World J Gastroenterol (2016) 0.86
Risk factors for osteoporosis in inflammatory bowel disease patients. World J Gastrointest Pathophysiol (2015) 0.80
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet (2001) 10.29
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Diagnosis of osteoporosis and assessment of fracture risk. Lancet (2002) 7.38
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med (1997) 6.88
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) (2007) 3.51
Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev (2002) 3.46
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr (2008) 3.04
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2009) 2.58
Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47
Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology (1994) 2.45
The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med (2000) 2.37
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology (2005) 2.29
A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease. Am J Gastroenterol (2006) 2.29
AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology (2003) 2.17
Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet (1988) 2.13
Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol (2002) 2.05
Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol (2008) 1.92
Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut (2000) 1.81
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol (2006) 1.79
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest (1998) 1.75
The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol (2006) 1.66
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology (2000) 1.64
Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr (2013) 1.62
Reduced bone density in patients with inflammatory bowel disease. Gut (1997) 1.56
High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2008) 1.43
Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial. J Crohns Colitis (2012) 1.43
Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res (2007) 1.42
Management of inflammatory bowel disease with vitamin D: beyond bone health. J Crohns Colitis (2011) 1.40
Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 1.39
Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis (2009) 1.35
Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr (1985) 1.30
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol (2005) 1.29
Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology (2012) 1.27
Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. J Crohns Colitis (2011) 1.25
Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.25
Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology (2002) 1.21
Vitamin D as a therapy for colitis: a systematic review. J Crohns Colitis (2012) 1.18
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut (2004) 1.17
Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis (2011) 1.11
Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med (1996) 1.10
Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr (1991) 1.09
Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol (2008) 1.05
Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2002) 1.01
Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol (1994) 0.98
Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology (1998) 0.96
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol (1995) 0.95
Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol (1996) 0.95
Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn's disease. Inflamm Bowel Dis (2013) 0.95
A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther (1996) 0.93
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis (2007) 0.93
Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease. Dig Dis (2006) 0.93
Monitoring osteoporosis treatment. Best Pract Res Clin Rheumatol (2009) 0.92
Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Inflamm Bowel Dis (2009) 0.91
Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther (1998) 0.89
[Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors]. Z Gastroenterol (1999) 0.87
The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol (1999) 0.86
Determination of bone age in pediatric patients with Crohn's disease should become part of routine care. Inflamm Bowel Dis (2013) 0.85
Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease. Osteoporos Int (2006) 0.85
Body composition and muscle strength as predictors of bone mineral density in Crohn's disease. J Bone Miner Metab (2009) 0.85
Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol (1999) 0.83
Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr (1995) 0.82
A case-control study on risk factors of osteoporosisin patients with Crohn's disease. Arch Iran Med (2009) 0.81
Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol (1998) 0.81
Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease. J Emerg Med (2007) 0.81
Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study. BMC Gastroenterol (2012) 0.81
Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2012) 0.81
Increase of bone mineral density with sodium fluoride in patients with Crohn's disease. Eur J Gastroenterol Hepatol (2000) 0.80
Vitamin D deficiency and insufficiency are common in ulcerative colitis patients after ileal pouch-anal anastomosis. Inflamm Bowel Dis (2013) 0.80
Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis. J Gastrointestin Liver Dis (2011) 0.79
Association of dehydroepiandrosterone sulfate and testosterone deficiency with bone turnover in men with inflammatory bowel disease. Int J Colorectal Dis (2002) 0.79
Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D. World J Gastroenterol (2011) 0.78
Effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease. Horm Res Paediatr (2010) 0.78
Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. Br J Rheumatol (1997) 0.78
Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density. BMC Gastroenterol (2008) 0.78
A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial. Am J Gastroenterol (2011) 0.77
Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease. Intern Med (2009) 0.77
Hypomagnesaemia-induced hypocalcaemia: concentrations of parathyroid hormone, prolactin and 1,25-dihydroxyvitamin D during magnesium replenishment. Magnes Res (1992) 0.76